Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30763142

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Mar 28
First author
Fizazi K

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 May;16(5):273. doi: 10.1038/s41571-019-0191-7.
    note
    Source null
    related pmid
    30809027
    relationship
    Comment in
  2. citation
    Cancer Discov. 2019 Apr;9(4):OF6. doi: 10.1158/2159-8290.CD-NB2019-029.
    note
    Source null
    related pmid
    30824428
    relationship
    Comment in
  3. citation
    Eur Urol. 2019 Oct;76(4):536-537. doi: 10.1016/j.eururo.2019.04.028.
    note
    Source null
    related pmid
    31101535
    relationship
    Comment in
  4. citation
    Asian J Androl. 2020 Jan-Feb;22(1):76-78. doi: 10.4103/aja.aja_52_19.
    note
    Source null
    related pmid
    31249268
    relationship
    Comment in
  5. citation
    J Urol. 2019 Oct;202(4):660-661. doi: 10.1097/JU.0000000000000443.
    note
    Source null
    related pmid
    31294661
    relationship
    Comment in
  6. citation
    Future Oncol. 2021 May;17(14):1699-1707. doi: 10.2217/fon-2020-1291.
    note
    Source null
    related pmid
    33554636
    relationship
    Comment in
  7. citation
    N Engl J Med. 2022 Sep 1;387(9):860. doi: 10.1056/NEJMx220007.
    note
    Source null
    related pmid
    36053527
    relationship
    Erratum in

Authors and identifiers

  1. name
    Fizazi K
    type
    Author
  2. name
    Shore N
    type
    Author
  3. name
    Tammela TL
    type
    Author
  4. name
    Ulys A
    type
    Author
  5. name
    Vjaters E
    type
    Author
  6. name
    Polyakov S
    type
    Author
  7. name
    Jievaltas M
    type
    Author
  8. name
    Luz M
    type
    Author
  9. name
    Alekseev B
    type
    Author
  10. name
    Kuss I
    type
    Author
  11. name
    Kappeler C
    type
    Author
  12. name
    Snapir A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fizazi K
    type
    Author
  2. name
    Shore N
    type
    Author
  3. name
    Tammela TL
    type
    Author
  4. name
    Ulys A
    type
    Author
  5. name
    Vjaters E
    type
    Author
  6. name
    Polyakov S
    type
    Author
  7. name
    Jievaltas M
    type
    Author
  8. name
    Luz M
    type
    Author
  9. name
    Alekseev B
    type
    Author
  10. name
    Kuss I
    type
    Author
  11. name
    Kappeler C
    type
    Author
  12. name
    Snapir A
    type
    Author
bibliography ids
  1. nci-bib-6af69b1dd52cebdde54419ed
book metadata
content sha256
4108583e1702c15f712c562fbe5a6842f64ea51be9573dee1959451f990bb6df
document type
citation
dois
  1. 10.1056/NEJMoa1815671
electronic publication date
display
2019 Feb 14
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30763142
immutable id
pubmed:30763142@4108583e1702c15f712c562fbe5a6842f64ea51be9573dee1959451f990bb6df
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
13
name
The New England journal of medicine
nlm unique id
0255562
pages
1235-1246
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 May;16(5):273. doi: 10.1038/s41571-019-0191-7.
    note
    Source null
    related pmid
    30809027
    relationship
    Comment in
  2. citation
    Cancer Discov. 2019 Apr;9(4):OF6. doi: 10.1158/2159-8290.CD-NB2019-029.
    note
    Source null
    related pmid
    30824428
    relationship
    Comment in
  3. citation
    Eur Urol. 2019 Oct;76(4):536-537. doi: 10.1016/j.eururo.2019.04.028.
    note
    Source null
    related pmid
    31101535
    relationship
    Comment in
  4. citation
    Asian J Androl. 2020 Jan-Feb;22(1):76-78. doi: 10.4103/aja.aja_52_19.
    note
    Source null
    related pmid
    31249268
    relationship
    Comment in
  5. citation
    J Urol. 2019 Oct;202(4):660-661. doi: 10.1097/JU.0000000000000443.
    note
    Source null
    related pmid
    31294661
    relationship
    Comment in
  6. citation
    Future Oncol. 2021 May;17(14):1699-1707. doi: 10.2217/fon-2020-1291.
    note
    Source null
    related pmid
    33554636
    relationship
    Comment in
  7. citation
    N Engl J Med. 2022 Sep 1;387(9):860. doi: 10.1056/NEJMx220007.
    note
    Source null
    related pmid
    36053527
    relationship
    Erratum in
outcomes validated
false
pmid
30763142
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
47002663985713138e76cc866f7481febd3ce62494be5f7b40a2dfea3b7b669c
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Mar 28
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30763142/
title
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.

Preserved source evidence · Not medical advice